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Abstract
Background: Matrix metalloproteinases (MMPs) are involved in the degradation of the extracellular
matrix of the intervertebral disc. A SNP for guanine insertion/deletion (G/D), the -1607 promoter
polymorphism, of the MMP1 gene was found significantly affecting promoter activity and corresponding
transcription level. Hence it is a good candidate for genetic studies in DDD.
Methods: Southern Chinese volunteers between 18 and 55 years were recruited from the population.
DDD in the lumbar spine was defined by MRI using Schneiderman's classification. Genomic DNA was
isolated from the leukocytes and genotyping was performed using the Sequenom® platform. Association
and Hardy-Weinberg equilibrium checking were assessed by Chi-square test and Mann-Whitney U test.
Results: Our results showed substantial evidence of association between -1607 promoter polymorphism
of MMP1 and DDD in the Southern Chinese subjects. D allelic was significantly associated with DDD (p
value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–1.90) while Genotypic association on the presence
of D allele was also significantly associated with DDD (p value = 0.046, odds ratio = 1.50 with 95% CI =
1.01–2.24). Further age stratification showed significant genotypic as well as allelic association in the group
of over 40 years (genotypic: p value = 0.035, odds ratio = 1.617 with 95% CI = 1.033–2.529; allelic: p value
= 0.033, odds ratio = 1.445 with 95% CI = 1.029–2.029). Disc bulge, annular tears and the Schmorl's nodes
were not associated with the D allele.
Conclusion: We demonstrated that individuals with the presence of D allele for the -1607 promoter
polymorphism of MMP1 are about 1.5 times more susceptible to develop DDD when compared with
those having G allele only. Further association was identified in individuals over 40 years of age. Disc bulge,
annular tear as well as Schmorl's nodes were not associated with this polymorphism.
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Low back pain (LBP) affects 70% to 80% of all people at
some time during their life [1]. The annual prevalence
ranges from 15% to 45%, with a point prevalence averag-
ing 30% [1]. Degenerative Disc Disease (DDD) in the
lumbar spine or lumbar disc degeneration is a major cause
of LBP [2-7].
Up to now, there is only a limited understanding of DDD,
with the underlying pathophysiological and molecular
mechanisms remain un-elucidated. Studies suggested that
environmental factors such as physical loading, motor
vehicle driving, vibration and smoking may have a role [8-
11]. However, there is increasing evidence that DDD is a
genetic disorder [12], with reports of predisposition in
association with certain genes, such as Taq I polymor-
phism of vitamin D receptor (VDR) gene [2,5,13,14], pol-
ymorphism of metalloproteinase-3 (MMP3) gene [15-
17], mutations in collagen IX genes (COL9A2 and
COL9A3) [18-22], Sp1 polymorphism of collagen I gene
(COL1A1) [23,24], polymorphism of cartilage intermedi-
ate layer protein (CILP) [25] as well as aggrecan gene pol-
ymorphism [26]. The involvement of multiple genes is
not uncommon, as aetiology is often multifactorial in
common diseases such as DDD [12].
In the process of disc degeneration, degradation of the
extracellular matrix (ECM) is a key event. Collagens are
one of the major constituents of the ECM. They make up
20% dry mass of the nucleus pulposus and 60% dry mass
of the annulus fibrosis. Approximately 80% of the colla-
gens in the intervertebral disc consist of fibrillar collagen
types I and II [16,27]. Matrix metalloproteinases (MMPs)
are the family of degradation enzymes that break down
the components of the ECM [17,27,28]. In particular,
MMP1 is a collagenase which cleaves the triple helical part
of the fibrillar collagen of types I, II and III, and is pro-
posed to initiate the degradation process [29-35]. The
cleaved fragments have a lower melting temperature than
37°C, which are then further cleaved by other MMPs.
Similarly, MMP1 can cleave aggrecan at the major MMP
cleavage sites between the G1 and G2 domains contribut-
ing to the breakdown of aggrecan [36].
Expression of MMPs is generally low in normal cells
which allows for healthy tissue turnover. On the other
hand, the level of MMPs increases substantially under
pathological conditions and results in ECM degradation.
A single nucleotide polymorphism (SNP) for guanine
insertion/deletion (G/D) at position -1607 in the pro-
moter region of the MMP1 gene (-1607 polymorphism)
results in creation of binding sites for Ets transcription fac-
tor family [29]. Upon the interaction of adjacent AP-1 site,
the promoter activity and hence the transcription level of
MMP1 can be considerably increased [29,30].
In the present study, the association between this pro-
moter SNP and DDD was investigated in a population-
based dataset [14,22]. We demonstrated significant asso-
ciation with DDD and the deletion of guanine is sug-




The study was approved by the local ethics committee and
informed consent was obtained. Individuals of Southern
Chinese origin were recruited by open invitation from the
general population. All the recruited subjects subse-
quently underwent magnetic resonance imaging (MRI) of
the lumbar spine and their blood was obtained for DNA
extraction and genotyping analysis.
The MRI examinations were performed at the Jockey Club
MRI Engineering Centre using a 0.2T Profile open MRI
system (General Electric Medical System, Milwaukee, WI).
Sagittal T2-weighted fast spin echo sequences (TR = 3000
ms, TE = 92 ms, slice thickness = 5 mm) were used to
image the lumbar spine with a built-in flexible body coil.
Despite the relative low field, previous studies have dem-
onstrated this to be sensitive enough to identify abnor-
malities associated with DDD [14,22].
DDD was diagnosed on the basis of signal intensity
changes within the nucleus pulposus (NP) of the interver-
tebral discs (IVDs) of the lumbar spine and graded using
the Schneiderman's classification scheme [37]. Grade 0
was used to indicate normal disc with hyperintense signal
within the NP, grade 1 for a slight decrease in signal inten-
sity in the NP, grade 2 for a generalized hypointense NP
and grade 3 for a hypointense NP with disc space narrow-
ing. All the MRI scans were analyzed and rated by two
experienced physicians blinded to the results of the
genetic analysis and clinical history. Differences were
reviewed by the two raters and settled by consensus. The
score for each disc (0–3) was then summated to create a
DDD score for the whole lumbar spine (0–15) as previ-
ously described [14]. To define the affection status using
DDD score, a score of 0 was used to indicate the absence
of disc degeneration, while a score of 2 or above was used
to indicate the presence of degeneration. Individuals with
DDD score of 1 are considered as borderline degeneration
and was the area of the majority of disagreements between
the 2 raters and hence those with DDD score of 1 was con-
sidered unknown affection status and excluded from anal-
ysis [14,22].
Disc bulge was defined in discs where it has protruded
posteriorly beyond a line connecting the posterior mar-
gins of the adjacent vertebral bodies. In addition, annular
tears and Schmorl's nodes were assessed [14]. AnnularPage 2 of 6
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the posterior annulus surrounded by a dark rim.
Schmorl's nodes were defined as areas of endplate irregu-
larities in which the darkened rim of the vertebral end-
plate has indented into the vertebral body.
SNP genotyping
Genomic DNA was isolated from the leukocytes and the
quality as well as quantity measured by spectrophotome-
try. Genotyping was performed using the Sequenom® plat-
form. The Mass ARRAY AssayDesign software
(Sequenom) was used to design amplification and allele-
specific extension primers. The extension primer (5'-
GTAGTTAAATAATTAGAAAG-3') was designed to hybrid-
ize to the amplicon near the SNP site for the extension of
a single base or a few bases depending on the genotype of
the allele. PCR reactions (Forward primer: 5'-ACGTT-
GGATGGAACTCACATGTTATGCCAC-3'; Reverse-primer:
5'-ACGTTGGATGCTTCAGTATATCTTGGATTG-3') were
set up in 384-well plates at 6 µL total volume per reaction
and the reaction mix contains: 5 ng genomic DNA, 0.3
pmol each of specific forward and reverse primers, 200
µM of each dNTP, 3.25 mM MgCl2 and 0.2 unit of Hot-
StarTaq polymerase (5U/µL, Qiagen, Valencia, CA). The
PCR condition was: 95°C for 15 min, 45 cycles of 95°C
for 20 sec, 56°C for 30 sec and 72°C for 1 min, followed
by 72°C for 3 min. The treatment of PCR products with
alkaline phosphatase and mass extend reactions were all
performed according to manufacturer's (Sequenom) pro-
tocol. The final base-extension products were desalted
using SpectroClean resin (Sequenom), mixed with 3-
hydroxypicolinic acid and analyzed using a modified
Brucker Autoflex MALDI-TOF mass spectrometer
(Brucker, Billerica, MA).
Statistical analysis
Association and Hardy-Weinberg equilibrium checking
were assessed by χ2 test and Mann-Whitney U test. Odds
ratios and other statistical measures were calculated by
SPSS 14.0 software.
Results
A total of 691 individuals were genotyped for the study
with 266 males and 425 females. In common with previ-
ous studies, no significant differences could be detected in
disease predisposition between the 2 genders and there-
fore no gender stratification was carried out [11,13,14].
Analysis of the D allele showed an over representation in
the case group. The D allele conferred a higher risk (1.4
times) of developing DDD when compared to the G allele
(P-value = 0.027, odds ratio = 1.41 with 95% CI = 1.04–
1.90) (Table 1). Genotypic association on the presence of
the D allele was also significantly associated with DDD (P-
value = 0.046, odds ratio = 1.50 with 95% CI = 1.01–2.24)
(Table 2).
Because DDD is age related and 2 risk factors, VDR [14]
and the COL9A2 [22], have previously been demonstrated
to be age-dependent, we also analyzed this MMP1 associ-
ation to DDD stratified by age group. Using a stratifica-
tion as in a previous study [14], no significant association
was detected in an under-40-year age group (P-value = 0.5,
OR = 1.26 with 95% CI = 0.64–2.46). However, in the
over-40-year age group, the association was significant (P-
value = 0.03, OR = 1.46 with 95% CI = 1.03–2.03) (Tables
1 &2).
In addition, we assessed the difference in the distribution
of the DDD score for the D-allele+ (either DD or DG gen-
otype) and D-allele- (GG genotype) groups by Mann-
Whitney U test. It was found that the distribution of the
DDD score was significantly different between the D-
allele+ and D-allele- groups (p value = 0.028) with D-
allele+ group having higher DDD score.
Apart from DDD, association was tested on disc bulge,
annular tear as well as Schmorl's nodes, no significant
association with these phenotypes were found with the
MMP1 promoter polymorphism (Table 3).
Discussion
This is the first report of an association of a SNP in the
promoter region of MMP1 with DDD. DDD is a complex
multifactorial disease. It has been suggested that disc
degeneration is highly correlated to age [15,38-41] and
age stratification was performed in previous studies
[14,22]. Our results indicated that the association of DDD
Table 1: Allelic association of DDD with the -1607 polymorphism of MMP1
Total Age ≤ 40 Age > 40
G (%) D (%) G (%) D (%) G (%) D (%)
Control 170 (69.7) 74 (30.3) 31 (67.4) 15 (32.6) 139 (70.2) 59 (29.8)
Case 593 (62.0) 363 (38.0) 143 (62.2) 87 (37.8) 450 (62.0) 276 (38.0)
OR (95% CI) 1.41 (1.04–1.90) 1.26 (0.64–2.46) 1.46 (1.03–2.03)
p value 0.027 0.503 0.033
Note: The G allele is the reference allele of the calculation of ORs.Page 3 of 6
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jects over 40 years of age.
MMP1 is involved in the cleavage of fibrillar collagens I, II
and III [29-35]. Type I collagen is found extensively within
the annulus fibrosus and bony end-plate, while Type II is
the predominant collagen in the inner annulus, nucleus
pulposus as well as the cartilaginous end-plate [16,27].
Previous studies in tumor cell lines showed that an over-
representation of the G allele of this promoter SNP
resulted in increased MMP1 transcriptional activity, hence
more aggressive matrix degradation [29]. This was pro-
posed to be a mechanism in cancer progression and was
proven in subsequent functional studies which showed
that the G allele created additional binding sites for the Ets
family of transcription factors [29]. These Ets binding sites
(-1607 bp) work cooperatively with a nearby AP-1 site (-
1602 bp) to enhance promoter activity by at least 2 folds
[29,30]. With the increased promoter activity and hence
transcription level, the presence of the G allele could con-
sider to be risk factor for matrix degradation.
Although we found an association with this promoter
SNP in MMP1, our result showed the presence of the D
allele resulted in an increased risk of DDD, and not the
anticipated G allele. Previous in vitro studies have shown
that the G allele is associated with higher expression levels
of MMP1 [29,30]. Thus, individuals with the D allele with
increase risk for DDD could not be explained by increased
susceptibility to matrix degradation because there is no
over-expression of MMP1.
This association may be explained in a number of ways.
First, the frequency for D allele is high in different ethnic
populations with 62.5% and 56.7% for African and Cau-
casian respectively (NCBI database), and 36.4% for
Southern Chinese. The high frequency of D allele may
indicate that the D allele is a common ancestor allele,
which might be in linkage disequilibrium with unknown
disease-causing polymorphism within the same gene. Sec-
ondly, MMP1 is located in a gene cluster on chromosome
11 with other MMP genes (MMP-3, 7, 8, 10, 12, 13, 20
and 26). It is possible that the observed association is the
result of linkage disequilibrium between this MMP1 pro-
moter polymorphism and polymorphisms in other
nearby MMP genes. Moreover, despite the Ets binding site
can cooperate with AP-1 site to enhance transcription of
MMP1, this polymorphism has yet to be tested in interver-
tebral disc tissues, to see whether it affects the transcrip-
tion level of MMP1. It maybe that gene expression be
differentially displayed in a tissue-specific manner. In
addition, expressional activity of MMP1 may also be influ-
enced differentially in response to cytokines and growth
factors. Even in the case of cancer, allele corresponding to
elevated MMP1 activity (expected to have increased sus-
ceptibility to cancer and poor prognosis) was unexpect-
edly found to have favourable prognosis with colorectal
cancer and no association with tumor characteristics [42].
Thus further replications of association in other ethnic
populations would help substantiate findings in this
study.
Conclusion
In summary, we have performed a case-control associa-
tion study to test for association between this promoter
SNP (-1607 polymorphism) of MMP1 and DDD. We have
demonstrated this promoter polymorphism was signifi-
cantly associated with increased susceptibility to DDD in
our Southern Chinese population, especially in individu-
als over 40 years of age. Disc bulge, annular tear as well as
Schmorl's nodes were not associated with this polymor-
phism.
Competing interests
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Table 2: Genotypic association of LDD with the -1607 polymorphism of MMP1
Total Age ≤ 40 Age > 40
GG (%) DD/DG (%) GG (%) DD/DG (%) GG (%) DD/DG (%)
Control 58 (47.5) 64 (52.5) 9 (39.1) 14 (60.9) 49 (49.5) 50 (50.5)
Case 180 (37.7) 298 (62.3) 43 (37.4) 72 (62.6) 137 (37.7) 226 (62.3)
OR (95% CI) 1.50 (1.01–2.24) 1.08 (0.43–2.70) 1.62 (1.03–2.53)
p value 0.046 0.875 0.035
Note: The GG genotype is reference genotype of the calculation of ORs.
Table 3: Genotypic association of other degenerative changes 
with the -1607 polymorphism of MMP1
GG (%) DD/DG (%) p value
Disc bulge Control 122 (42.7) 164 (57.3) 0.316
Case 113 (38.6) 180 (61.4)
Annular tear Control 215 (41.0) 309 (59.0) 0.430
Case 55 (37.4) 92 (62.6)
Schmorl's node Control 239 (40.0) 358 (60.0) 0.758
Case 31 (41.9) 43 (58.1)Page 4 of 6
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